Weng Guizhen, Wu Xiaolan, Zheng Suhui
Department of Oncology Nursing, Fujian Medical University Union Hospital, Fuzhou, Fujian, China.
School of Nursing, Fujian Medical University, Fuzhou, Fujian, China.
Cancer Med. 2025 Apr;14(7):e70841. doi: 10.1002/cam4.70841.
This study aimed to analyze the influence factors affecting catheter-related bloodstream infection, catheter-related thrombosis and catheter-related local complication, respectively, and to explore the relationship among them, as well as the influence of catheter-related bloodstream infection, catheter-related thrombosis and catheter-related local complication on cancer patients' death.
The clinical data of 605 patients with solid tumors who underwent PICC from March 2019 to January 2020 in a Chinese hospital were retrospectively analyzed. Chi-square test and logistic regression analyses were used to examine the influence factors affecting catheterrelated bloodstream infection, catheter-related thrombosis and catheterrelated local complication, respectively, and their influence on cancer patients' death during the follow-up period.
The results of logistic regression analyses showed that gender, PICC vascular, PICC tip condition, whether anticoagulant therapy and thrombus location were influence factors of catheter-related bloodstream infection (p < 0.05), however, only whether anticoagulant therapy was risk factors of catheter-related thrombosis [odds ratio (OR) = 7.549, 95% confidence interval (CI): 2.9-19.652, p < 0.05]. In addition, surgical history, PICC tip condition and thrombus location were influence factors of catheter-related local complication (p < 0.05). Furthermore, the results showed that after adjusted by all variables, only catheter-related bloodstream infection was risk factor of cancer patients' death (OR = 11.231, 95% CI: 3.23-39.053, p < 0.05). However, catheter-related thrombosis (OR = 0.793, 95% CI: 0.308-2.043, p > 0.05) and catheter-related local complication (OR = 1.815, 95% CI: 0.715-4.609, p > 0.05) were not significantly associated with patients' death.
Overall, the influence factors of catheter-related bloodstream infection, catheter-related thrombosis and catheter-related local complication were significantly different. Moreover, catheter-related bloodstream infection was the risk factor of cancer patients' death. However, catheter-related thrombosis and catheter-related local complication were not significantly associated with patients' death.
本研究旨在分别分析影响导管相关血流感染、导管相关血栓形成及导管相关局部并发症的因素,探讨它们之间的关系,以及导管相关血流感染、导管相关血栓形成及导管相关局部并发症对癌症患者死亡的影响。
回顾性分析2019年3月至2020年1月在中国一家医院接受经外周静脉穿刺中心静脉置管(PICC)的605例实体瘤患者的临床资料。采用卡方检验和逻辑回归分析分别检验影响导管相关血流感染、导管相关血栓形成及导管相关局部并发症的因素,以及它们在随访期间对癌症患者死亡的影响。
逻辑回归分析结果显示,性别、PICC血管、PICC尖端情况、是否进行抗凝治疗及血栓部位是导管相关血流感染的影响因素(p<0.05),然而,只有是否进行抗凝治疗是导管相关血栓形成的危险因素[比值比(OR)=7.549,95%置信区间(CI):2.9 - 19.652,p<0.05]。此外,手术史、PICC尖端情况及血栓部位是导管相关局部并发症的影响因素(p<0.05)。此外,结果显示在对所有变量进行调整后,只有导管相关血流感染是癌症患者死亡的危险因素(OR = 11.231,95% CI:3.23 - 39.053,p<0.05)。然而,导管相关血栓形成(OR = 0.793,95% CI:0.308 - 2.043,p>0.05)和导管相关局部并发症(OR = 1.815,95% CI:0.715 - 4.609,p>0.05)与患者死亡无显著相关性。
总体而言,导管相关血流感染、导管相关血栓形成及导管相关局部并发症的影响因素有显著差异。此外,导管相关血流感染是癌症患者死亡的危险因素。然而,导管相关血栓形成和导管相关局部并发症与患者死亡无显著相关性。